PRLBNYSEFabricated Structural Metal ProductsFiscal year ends December 31
Proto Labs Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$87.40+1.75 (+2.04%)
Close on Oct 19, 2026
- Market cap
- $2.13B
- P/E (TTM)
- 69.9
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
44.5%−5.7 pts over 5 years
Operating margin
4.7%−9.1 pts over 5 years
Net margin
4.0%−7.7 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.4% | +3.0% | +4.2% | +7.3% | |
| Gross profit | +6.2% | +3.2% | +1.7% | +4.4% | |
| Operating income | +26.1% | – | -15.9% | -9.4% | |
| Net income | +28.0% | – | -16.0% | -7.5% | |
| EPS, diluted | +33.3% | – | -14.2% | -6.7% | |
| Free cash flow | -13.1% | +13.9% | -0.1% | +11.7% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 12.1% | 8.3% | 3.2% | |
| Return on assets | 11.0% | 7.2% | 2.8% | |
| Current ratio | 6.74 | 4.82 | 3.49 | |
| Inventory turnover | 13.7× | 20.7× | 22.2× | |
| Capex to revenue | 11.3% | 10.8% | 2.8% | |
| Diluted shares | 27M | 27M | 24M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Proto Labs generated $342.93M from operations and spent $308.15M on capital expenditure, dividends and share buybacks. 35% of that went back into the business.
Generated
$342.93M
Used
$308.15M
Capital expenditure$108.02M35%Dividends$00%Share buybacks$200.13M65%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin4.0%
×Asset turnover0.71×
×Equity multiplier1.12×
=Return on equity, FY20253.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.0% | 0.71× | 1.12× | 3.2% |
| FY2024 | 3.3% | 0.66× | 1.11× | 2.4% |
| FY2023 | 3.4% | 0.64× | 1.13× | 2.5% |
| FY2022 | -21.2% | 0.56× | 1.13× | -13.6% |
| FY2021 | 6.8% | 0.58× | 1.14× | 4.5% |
| FY2020 | 11.7% | 0.61× | 1.15× | 8.3% |
| FY2019 | 13.9% | 0.71× | 1.15× | 11.3% |
| FY2018 | 17.2% | 0.78× | 1.13× | 15.3% |
| FY2017 | 15.0% | 0.74× | 1.11× | 12.3% |
| FY2016 | 14.3% | 0.77× | 1.10× | 12.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$21.24M
- Cash generatingOperating cash flow above zero$74.50M
- Return on assets improvedROA up on the prior year2.1% → 2.9%
- Earnings backed by cashOperating cash flow above net income$74.50M vs $21.24M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose3.66 → 3.49
- No dilutionShare count did not rise25M → 24M
- Gross margin improvedGross margin up on the prior year44.56% → 44.48%
- More efficientAsset turnover rose0.65 → 0.72